November 22, 2024

FDA Approves Bimzelx for Hidradenitis Suppurativa

Bimzelx is the first hidradenitis suppurativa treatment selectively targeting both interleukin-17A and interleukin-17F.

Conexiant

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

Conexiant

November 18, 2024

Renowned Dermatologist Goldsmith Dies at 86

"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.

Conexiant

November 05, 2024

Catholic Hospitals Shift to Megacorporations as Nuns Vanish

Discover how the original mission of Catholic hospitals led by nuns has transformed into a question of identity and purpose in modern healthcare.

KFF Health News

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

October 11, 2024

Skin Pigmentation: Rethinking Drug Efficacy

With skin pigmentation influencing drug binding and potentially altering therapeutic outcomes, understanding melanin's role in pharmacokinetics is key to advancing equitable treatments.

Conexiant

June 05, 2024

Noncompete Ban May Not Help Nonprofit Workers

Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.

KFF Health News

July 23, 2024

Drug Industry Middlemen Defend Model at Congressional Hearing

They attributed the high costs to "patent abuses" by drug manufacturers, which delay the launch of cheaper generic and biosimilar medicines.

Reuters

May 17, 2024

Watch: John Oliver Dishes on KFF Health News’ Opioid Settlements Series

Recent reporting and analysis show how opioid settlement funds are being allocated by state and local governments in the US, shedding light on the significant restitution efforts by manufacturers, distributors, and retailers.

KFF Health News